News & Events

17/06/2019

Top-quality pharma-grade Hyaluronic Acid available from Fidia

Fidia’s Hyaluronic Acid from fermentation has been recently granted the Certificate of Suitability (CEP, R0-CEP 2017-220-Rev 00) to the European Pharmacopeia, Sodium Hyaluronate Monograph, by EDQM (European Directorate for the Quality of Medicines).Certificates of suitability (CEPs) are accepted in…
19/04/2019

Fidia Announces Expansion of its Affiliate Network Worldwide

Fidia Pharma Egypt is headquartered in Cairo, with a sales team of 45 people and is market leader of IAHA products

Fidia Farmaceutici announces the expansion of its affiliate network, with the recent opening of Fidia Pharma Egypt, unlocking new opportunities in Middle East and Africa and meeting the varied needs of customers in different regions. Officially established in March 2019, Fidia Pharma Egypt is…
12/04/2019

Fidia Announces Expansion into the US Dietary Supplement Market with Launch of CartiJoint™ FORTE

Unique formulation with a bioactive curcumin extract Bio-Curcumin Curcugreen™ (100% natural turmeric), glucosamine hydrochloride and chondroitin sulfate.

Fidia Farmaceutici is introducing CartiJoint™ FORTE, its first product in the dietary supplement category in the USA, through its wholly-owned subsidiary based in the U.S., Fidia Pharma USA Inc. CartiJoint™ FORTE is a dietary supplement that supports joint health and mobility with antioxidant…

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.